287840 — Intocell Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMid CapSucker Stock

Annual balance sheet for Intocell, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—
Source:	PROSPECTUS	PROSPECTUS	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS
Status:	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	11,013	6,958	23,074
Net Total Accounts Receivable
Net Total Receivables	202	1,265	433
Prepaid Expenses
Total Other Current Assets
Total Current Assets	17,403	13,495	31,294
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	3,596	3,343	3,280
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	25,943	23,711	41,254
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	10,702	13,508	3,223
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Funded Status
Total Liabilities	12,716	16,190	16,504
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
ESOP Debt Guarantee
Other Equity
Total Equity	13,227	7,521	24,749
Total Liabilities & Shareholders' Equity	25,943	23,711	41,254
Total Common Shares Outstanding